Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457197 · ClinicalTrials.gov registry record · Phase 4
Quetiapine for Bipolar Disorder and Alcohol Dependence
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT00457197 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 90 participants.
The verdict
NCT00457197, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether an investigational drug called quetiapine can treat bipolar disorder, improve mood and reduce alcohol use and craving.
Interventions
- DRUG Placebo
- DRUG Quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457197
The ClinicalTrials.gov registry entry for NCT00457197 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00457197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00457197 about?
NCT00457197 is a clinical study titled "Quetiapine for Bipolar Disorder and Alcohol Dependence". The purpose of this study is to find out whether an investigational drug called quetiapine can treat bipolar disorder, improve mood and reduce alcohol use and craving.
What is the current status of trial NCT00457197?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2007-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00457197?
The interventions under investigation include: Placebo (DRUG), Quetiapine (DRUG).
Who is sponsoring clinical trial NCT00457197?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.